drugset / Trial / NCT02481791

Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia

NCT02481791

Phase 3 Unknown 35 enrolled Alder Hey Children's NHS Foundation Trust
NaSingle-groupOpen-labelSupportive care

Summary

What is the optimal maintenance dose of remifentanil to ensure apnoea, during breath hold episodes in children having cardiac MR imaging with general anaesthesia?

Timeline

Start
2015-07
Primary completion
2019-12-31
Completion
2019-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule Intravenous
Background Propofol Small molecule 100 ug/kg Intravenous

Indications